← Leaderboards
Lea Tenenholz Grinberg
Mayo Clinic Jacksonville
$17,312,791
Attributed
$34,122,655
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2011–25$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,122,655 · 12
By mechanism
R01$28,513,934 · 5
U54$2,041,662 · 3
K24$1,765,980 · 1
R56$1,476,181 · 2
R21$324,898 · 1
Top collaborators
- Thomas C Neylan15 shared
- Chunlei Liu5 shared
- Maria Concepcion Garcia Otaduy5 shared
- Bernardino Ghetti4 shared
- Melissa Erin Murray4 shared
- Elisa Resende2 shared
- Martin Kampmann1 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainS DiseaseTau ProteinsAreaNeurodegenerative DisordersAutopsyNeuronsPathologyNeuropathologyNerve DegenerationSymptomsPatternProgramsTissuesTauopathiesNeurobiologyAmyloid Beta-ProteinNeurofibrillary TanglesCognitiveMapsLinkLesionAffect
Grant awards (54)
Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease$2,937,723
R01 · FY2025 · AG
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP$1,390,787
R01 · FY2025 · AG
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression$612,227
R01 · FY2025 · AG
Neuropathological changes underlying clinical heterogeneity in Alzheimer dise$140,341
K24 · FY2025 · AG · contact PI
Core C: Human Tissue Validation$116,288
U54 · FY2025 · NS · contact PI
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$47,955
K24 · FY2025 · AG · contact PI
Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease$3,080,100
R01 · FY2024 · AG
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP$1,477,591
R01 · FY2024 · AG
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression$640,136
R01 · FY2024 · AG
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$188,296
K24 · FY2024 · AG · contact PI
Core C: Human Tissue Validation$129,200
U54 · FY2024 · NS · contact PI
Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease$3,450,540
R01 · FY2023 · AG
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP$805,134
R01 · FY2023 · AG
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression$793,588
R01 · FY2023 · AG · contact PI
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression$652,184
R01 · FY2023 · AG
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$188,296
K24 · FY2023 · AG · contact PI
Core C: Human Tissue Validation$129,200
U54 · FY2023 · NS · contact PI
Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease$3,067,743
R01 · FY2022 · AG
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP$804,861
R01 · FY2022 · AG
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression$782,671
R01 · FY2022 · AG · contact PI
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression$667,085
R01 · FY2022 · AG
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$188,296
K24 · FY2022 · AG · contact PI
Core C: Human Tissue Validation$129,200
U54 · FY2022 · NS · contact PI
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP$806,085
R01 · FY2021 · AG
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression$782,490
R01 · FY2021 · AG · contact PI
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression$709,446
R01 · FY2021 · AG
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$188,296
K24 · FY2021 · AG · contact PI
Better memory with literacy acquisition later in life: a randomized controlled trial$154,805
R21 · FY2021 · AG · contact PI
Core C: Human Tissue Validation$129,200
U54 · FY2021 · NS · contact PI
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression$33,686
R01 · FY2021 · AG · contact PI
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression$13,828
R01 · FY2021 · AG · contact PI
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression$784,751
R01 · FY2020 · AG · contact PI
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP$773,508
R01 · FY2020 · AG
Core B: Human Biology Validation Core$279,116
U54 · FY2020 · NS · contact PI
Better memory with literacy acquisition later in life: a randomized controlled trial$170,093
R21 · FY2020 · AG · contact PI
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$164,900
K24 · FY2020 · AG · contact PI
Linking Sleep Dysfunction to Tau-related Degeneration across AD Progression$772,707
R01 · FY2019 · AG · contact PI
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP$707,383
R01 · FY2019 · AG
Core B: Human Biology Validation Core$278,391
U54 · FY2019 · NS · contact PI
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$164,900
K24 · FY2019 · AG · contact PI
Uncovering mechanisms of selective vulnerability by CRISPR-based genetic screens$768,883
R56 · FY2018 · AG
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP$707,298
R56 · FY2018 · AG
Core B: Human Biology Validation Core$294,519
U54 · FY2018 · NS · contact PI
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$164,900
K24 · FY2018 · AG · contact PI
Core B: Human Biology Validation Core$280,203
U54 · FY2017 · NS · contact PI
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$164,900
K24 · FY2017 · AG · contact PI
Core B: Human Biology Validation Core$276,345
U54 · FY2016 · NS · contact PI
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease$164,900
K24 · FY2016 · AG · contact PI
Brainstem as an early site in AD and FTLD: closing the etiopathogenic gap$317,628
R01 · FY2015 · AG · contact PI
Brainstem as an early site in AD and FTLD: closing the etiopathogenic gap$351,506
R01 · FY2014 · AG · contact PI
Brainstem as an early site in AD and FTLD: closing the etiopathogenic gap$156,420
R01 · FY2014 · AG · contact PI
Brainstem as an early site in AD and FTLD: closing the etiopathogenic gap$349,540
R01 · FY2013 · AG · contact PI
Brainstem as an early site in AD and FTLD: closing the etiopathogenic gap$339,949
R01 · FY2012 · AG · contact PI
Brainstem as an early site in AD and FTLD: closing the etiopathogenic gap$452,637
R01 · FY2011 · AG · contact PI